SCHEMBL23551391

SCHEMBL23551391

CONc1ccc(N2CCC(O)(CC(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LDHA P00338 1/20 0.39
▸ LDHB P07195 1/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MAPT P10636 5/20 0.38
▸ NPY2R P49146 4/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23551503 0.90 L3MBTL1 (0.40) LMNAPOLBL3MBTL1KDM4ELDHA
SCHEMBL23551479 0.90 L3MBTL1 (0.40) LMNAPOLBL3MBTL1KDM4ELDHA
SCHEMBL31334108 0.84 MAPT (0.38) L3MBTL1NPC1RAB9AMAPTMEN1
SCHEMBL23551473 0.84 FFAR4 (0.41) LMNAL3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL29535010 0.84 MAPT (0.42) LMNAL3MBTL1KDM4ENPC1RAB9A
SCHEMBL29744638 0.84 MAPT (0.38) L3MBTL1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL23539031 0.84 MAPT (0.38) L3MBTL1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL23538815 0.84 MAPT (0.42) LMNAL3MBTL1KDM4ENPC1RAB9A
SCHEMBL25122064 0.83 MAPT (0.39) LMNAPOLBL3MBTL1NPC1RAB9A
Lithium SCHEMBL29946900 0.83 MAPT (0.41) LMNAL3MBTL1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127561-A1 ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR C4 THERAPEUTICS, INC. (US) 2021-06-24 — — WO disclosed
Send feedback